Estramustine phosphate sodium
磷酸雌莫司汀
Report date: 2022/03/01 14:05:34
NME
Base Information
Drug NameEstramustine phosphate sodium
Drug Alias Name +[14]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1981/12/24
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesPfizer Italia SrlPfizer LtdNippon Shinyaku Co Ltd
Inactive CompaniesKabi PharmaciaPfizer Canada UlcPharmacia & Upjohn
Active Indications
Inactive IndicationsN/A